Abstract
OBJECTIVES: As an alternative to statewide, mandated surveillance for antibiotic-resistant Streptococcus pneumoniae, a sentinel surveillance network of 27 hospitals was developed in Washington State. METHODS: The utility of targeted surveillance in population centers was assessed, current laboratory susceptibility testing practices were evaluated, and a baseline of pneumococcal resistance in Washington State was obtained for use in a statewide campaign promoting the judicious use of antibiotics. RESULTS: Between July 1997 and June 1998, 300 cases were reported; 67 (22%) had diminished susceptibility to penicillin. Only 191 (64%) were fully tested with penicillin and an extended-spectrum cephalosporin (ESC) as nationally recommended; 10.5% were resistant to penicillin and 6.8% were resistant to an ESC. The number of isolates inadequately tested declined through the year. The findings were similar to those from more comprehensive active surveillance in Oregon for the same time period. CONCLUSIONS: Targeted surveillance may be an adequate alternative for limited monitoring of antibiotic resistance for states that choose not to mandate reporting.
Full Text
The Full Text of this article is available as a PDF (78.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dowell S. F., Butler J. C., Giebink G. S., Jacobs M. R., Jernigan D., Musher D. M., Rakowsky A., Schwartz B. Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999 Jan;18(1):1–9. [PubMed] [Google Scholar]
- Frick P. A., Black D. J., Duchin J. S., Deliganis S., McKee W. M., Fritsche T. R. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State. West J Med. 1998 Dec;169(6):364–369. [PMC free article] [PubMed] [Google Scholar]
- Jernigan D. B., Cetron M. S., Breiman R. F. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group. JAMA. 1996 Jan 17;275(3):206–209. [PubMed] [Google Scholar]
- Jorgensen J. H., Swenson J. M., Tenover F. C., Ferraro M. J., Hindler J. A., Murray P. R. Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol. 1994 Oct;32(10):2448–2459. doi: 10.1128/jcm.32.10.2448-2459.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luna V. A., Jernigan D. B., Tice A., Kellner J. D., Roberts M. C. A novel multiresistant Streptococcus pneumoniae serogroup 19 clone from Washington State identified by pulsed-field gel electrophoresis and restriction fragment length patterns. J Clin Microbiol. 2000 Apr;38(4):1575–1580. doi: 10.1128/jcm.38.4.1575-1580.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schuchat A., Robinson K., Wenger J. D., Harrison L. H., Farley M., Reingold A. L., Lefkowitz L., Perkins B. A. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997 Oct 2;337(14):970–976. doi: 10.1056/NEJM199710023371404. [DOI] [PubMed] [Google Scholar]